Birnbaumer Philipp, Traninger Heimo, Sattler Matteo C, Borenich Andrea, Hofmann Peter
Institute of Human Movement Science, Sport & Health, University of Graz, 8010 Graz, Austria.
ZARG Centre for Outpatient Rehabilitation, 8021 Graz, Austria.
J Funct Morphol Kinesiol. 2021 Jul 13;6(3):61. doi: 10.3390/jfmk6030061.
(1): Heart rate performance curve (HRPC) in incremental exercise was shown to be not uniform, causing false intensity estimation applying percentages of maximal heart rate (HR). HRPC variations are mediated by β-adrenergic receptor sensitivity. The aim was to study age and sex dependent differences in HRPC patterns in adults with β-blocker treatment (BB) and healthy controls (C). (2): A total of 535 (102 female) BB individuals were matched 1:1 for age and sex (male 59 ± 11 yrs, female 61 ± 11 yrs) in C. From the maximum incremental cycle ergometer exercise a first and second heart rate (HR) threshold (Th1 and Th2) was determined. Based on the degree of the deflection (kHR), HRPCs were categorized as regular (downward deflection (kHR > 0.1)) and non-regular (upward deflection (kHR < 0.1), linear time course). (3): Logistic regression analysis revealed a higher odds ratio to present a non-regular curve in BB compared to C (females showed three times higher odds). The odds for non-regular HRPC in BB versus C decreased with older age (OR interaction = 0.97, CI = 0.94-0.99). Maximal and submaximal performance and HR variables were significantly lower in BB ( < 0.05). %HR was significantly lower in BB versus C at Th2 (male: 77.2 ± 7.3% vs. 80.8 ± 5.0%; female: 79.2 ± 5.1% vs. 84.0 ± 4.3%). %P at Th2 was similar in BB and C. (4): The HRPC pattern in incremental cycle ergometer exercise is different in individuals receiving β-blocker treatment compared to healthy individuals. The effects were also dependent on age and sex. Relative HR values at Th2 varied substantially depending on treatment. Thus, the percentage of Pmax seems to be a stable and independent indicator for exercise intensity prescription.
(1):递增运动中的心率表现曲线(HRPC)显示并非均匀一致,这导致应用最大心率(HR)百分比时强度估计出现错误。HRPC的变化由β-肾上腺素能受体敏感性介导。目的是研究接受β受体阻滞剂治疗(BB)的成年人与健康对照者(C)在HRPC模式上的年龄和性别依赖性差异。(2):总共535名(102名女性)接受BB治疗的个体在年龄和性别上与C组进行1:1匹配(男性59±11岁,女性61±11岁)。从最大递增式蹬车运动中确定第一和第二心率(HR)阈值(Th1和Th2)。根据偏转程度(kHR),HRPC被分类为规则型(向下偏转(kHR>0.1))和非规则型(向上偏转(kHR<0.1),线性时间进程)。(3):逻辑回归分析显示,与C组相比,BB组出现非规则曲线的优势比更高(女性的优势比高出三倍)。BB组与C组相比,非规则HRPC的优势随着年龄增长而降低(OR交互作用=0.97,CI=0.94 - 0.99)。BB组的最大和次最大运动表现及HR变量显著更低(<0.05)。在Th2时,BB组的%HR显著低于C组(男性:77.2±7.3%对80.8±5.0%;女性:79.2±5.1%对84.0±4.3%)。BB组和C组在Th2时的%P相似。(4):与健康个体相比,接受β受体阻滞剂治疗的个体在递增式蹬车运动中的HRPC模式不同。这些影响也取决于年龄和性别。Th2时的相对HR值因治疗不同而有很大差异。因此,Pmax百分比似乎是运动强度处方的一个稳定且独立的指标。